These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Gavini E, Rassu G, Muzzarelli C, Cossu M, Giunchedi P. Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825 [Abstract] [Full Text] [Related]
5. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P. J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983 [Abstract] [Full Text] [Related]
10. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering. Cai DZ, Zeng C, Quan DP, Bu LS, Wang K, Lu HD, Li XF. Chin Med J (Engl); 2007 Feb 05; 120(3):197-203. PubMed ID: 17355821 [Abstract] [Full Text] [Related]
14. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Lin YH, Liang HF, Chung CK, Chen MC, Sung HW. Biomaterials; 2005 May 05; 26(14):2105-13. PubMed ID: 15576185 [Abstract] [Full Text] [Related]
15. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. Gordon S, Saupe A, McBurney W, Rades T, Hook S. J Pharm Pharmacol; 2008 Dec 05; 60(12):1591-600. PubMed ID: 19000363 [Abstract] [Full Text] [Related]
17. Chitosan based hydrogel microspheres as drug carriers. Vodná L, Bubeníková S, Lacík I, Chorvát D, Bakos D. Macromol Biosci; 2007 May 10; 7(5):629-34. PubMed ID: 17477445 [Abstract] [Full Text] [Related]
18. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Grenha A, Remuñán-López C, Carvalho EL, Seijo B. Eur J Pharm Biopharm; 2008 May 10; 69(1):83-93. PubMed ID: 18166446 [Abstract] [Full Text] [Related]
19. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228 [Abstract] [Full Text] [Related]
20. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Rawat M, Singh D, Saraf S, Saraf S. Drug Dev Ind Pharm; 2008 Feb 27; 34(2):181-8. PubMed ID: 18302037 [Abstract] [Full Text] [Related] Page: [Next] [New Search]